GB1542514A - 1-(benzazolylalkyl)piperidine derivatives - Google Patents
1-(benzazolylalkyl)piperidine derivativesInfo
- Publication number
- GB1542514A GB1542514A GB7627242A GB2724276A GB1542514A GB 1542514 A GB1542514 A GB 1542514A GB 7627242 A GB7627242 A GB 7627242A GB 2724276 A GB2724276 A GB 2724276A GB 1542514 A GB1542514 A GB 1542514A
- Authority
- GB
- United Kingdom
- Prior art keywords
- benzazolylalkyl
- formula
- piperidine derivatives
- salts
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
Abstract
1-(Benzazolylalkyl)piperidine derivatives of formula I <IMAGE> and their salts are prepared by subjecting an amine of formula <IMAGE> to N-alkylation to introduce the corresponding substituted alkyl radical. In the compounds of formula I, the substituents have the meanings given in Patent Claim 1. These compounds and their salts have a spasmolytic action and they are in particular used in agents to prevent vomiting.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59779375A | 1975-07-21 | 1975-07-21 | |
US05/687,139 US4066772A (en) | 1975-07-21 | 1976-05-17 | 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds |
KR7601697A KR810000334B1 (en) | 1975-07-21 | 1976-07-12 | Process for preparation 1-(benzazolylalkyl)-piperidine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1542514A true GB1542514A (en) | 1979-03-21 |
Family
ID=27348142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB7627242A Expired GB1542514A (en) | 1975-07-21 | 1976-06-30 | 1-(benzazolylalkyl)piperidine derivatives |
Country Status (25)
Country | Link |
---|---|
JP (1) | JPS5217475A (en) |
AT (1) | AT364358B (en) |
AU (1) | AU511027B2 (en) |
BG (1) | BG26526A3 (en) |
CA (1) | CA1085852A (en) |
CH (1) | CH623820A5 (en) |
CS (1) | CS202550B2 (en) |
DE (1) | DE2632870A1 (en) |
DK (1) | DK154950C (en) |
ES (3) | ES449740A1 (en) |
FI (1) | FI62667C (en) |
GB (1) | GB1542514A (en) |
HK (1) | HK14180A (en) |
IE (1) | IE43496B1 (en) |
IT (1) | IT1062614B (en) |
KE (1) | KE3215A (en) |
LU (1) | LU75354A1 (en) |
MY (1) | MY8100017A (en) |
NL (1) | NL187442C (en) |
NZ (1) | NZ181256A (en) |
PH (1) | PH13710A (en) |
PT (1) | PT65387B (en) |
RO (1) | RO70566A (en) |
SE (2) | SE426490B (en) |
YU (1) | YU39969B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4501749A (en) * | 1983-10-31 | 1985-02-26 | Merck & Co., Inc. | Peripherally selective dopamine antagonists in the treatment of ocular hypertension |
WO2004105765A1 (en) * | 2003-05-27 | 2004-12-09 | Janssen Pharmaceutica N.V. | Macrocyclic quinazoline derivatives as antiproliferative agents |
US8318731B2 (en) | 2007-07-27 | 2012-11-27 | Janssen Pharmaceutica Nv | Pyrrolopyrimidines |
US8492377B2 (en) | 2006-07-13 | 2013-07-23 | Janssen Pharmaceutica Nv | MTKI quinazoline derivatives |
US8772272B2 (en) | 2003-12-18 | 2014-07-08 | Janssen Pharmaceutica Nv | Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents |
US8846929B2 (en) | 2007-08-31 | 2014-09-30 | Purdue Pharma L.P. | Substituted-quinoxaline-type piperidine compounds and the uses thereof |
US9688691B2 (en) | 2004-12-08 | 2017-06-27 | Janssen Pharmaceutica Nv | Macrocyclic quinazole derivatives and their use as MTKI |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6248684A (en) * | 1985-08-26 | 1987-03-03 | Sumitomo Chem Co Ltd | Novel iodobutyrophenone derivative and production thereof |
JPS62251313A (en) * | 1986-04-25 | 1987-11-02 | 信越ポリマー株式会社 | Bundling device |
US6355659B1 (en) | 1994-07-29 | 2002-03-12 | Laboratorios Del Dr. Esteve, S.A. | 4-(4-Chlorophenyl)-1236-tetrahydro-1(1H-124-triazol-1-yl)butty)pyrideine and salts thereof; pharmaceutical compositions and method of treating psychoses utilizing same |
FR2723091B1 (en) * | 1994-07-29 | 1996-11-08 | Esteve Labor Dr | TETRAHYDROPYRIDINE- (6,4-HYDROXYPIPERIDINE) ALKYLAZOLES |
EP1997805A1 (en) * | 2007-06-01 | 2008-12-03 | Commissariat à l'Energie Atomique | Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans |
US9090618B2 (en) | 2012-12-27 | 2015-07-28 | Purdue Pharma L.P. | Substituted benzimidazole-type piperidine compounds and uses thereof |
CN108697700B (en) * | 2016-02-04 | 2021-08-17 | 辛多美制药有限公司 | Deuterated domperidone composition and method for treating disorders |
US11364226B2 (en) | 2017-06-30 | 2022-06-21 | Cinrx Pharma, Llc | Deuterated domperidone compositions, methods, and preparation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE633495A (en) * | 1962-06-13 | |||
BE633914A (en) * | 1962-06-22 | |||
US3629267A (en) * | 1968-10-28 | 1971-12-21 | Smith Kline French Lab | Benzoheterocyclicalkyl derivatives of 4-(2-keto -1-benzimidazolinyl)-piperidine 4-(2-keto - 1 - benzimidazolinyl) -1 2 3 6 tetrahydropyridine 1 - phenyl - 1 3 8-triazaspiro(4 5)decan - 4 - one and 2 4 9-triazaspiro(5 5)undecan-1 3 5-trione |
AU4698672A (en) * | 1972-09-22 | 1972-11-09 | Ciba-Geigy Ag | Azacycloaliphatic compounds, process for their manufacture and compositions containing them |
FR2218100A1 (en) * | 1973-02-20 | 1974-09-13 | Janssen Pharmaceutica Nv | Neuroleptic tricyclic derivs. - of benzimidazolinones and triazaspiro-4,5-decan-4-ones |
US3989707A (en) * | 1974-06-21 | 1976-11-02 | Janssen Pharmaceutica N.V. | Benzimidazolinone derivatives |
-
1976
- 1976-06-23 NZ NZ181256A patent/NZ181256A/en unknown
- 1976-06-30 GB GB7627242A patent/GB1542514A/en not_active Expired
- 1976-07-07 CA CA256,450A patent/CA1085852A/en not_active Expired
- 1976-07-07 RO RO7686860A patent/RO70566A/en unknown
- 1976-07-08 PH PH18663A patent/PH13710A/en unknown
- 1976-07-09 ES ES449740A patent/ES449740A1/en not_active Expired
- 1976-07-09 LU LU75354A patent/LU75354A1/xx unknown
- 1976-07-16 AU AU15964/76A patent/AU511027B2/en not_active Expired
- 1976-07-16 CS CS764688A patent/CS202550B2/en unknown
- 1976-07-19 IT IT50499/76A patent/IT1062614B/en active
- 1976-07-19 JP JP51085216A patent/JPS5217475A/en active Granted
- 1976-07-20 AT AT0534776A patent/AT364358B/en not_active IP Right Cessation
- 1976-07-20 CH CH929176A patent/CH623820A5/en not_active IP Right Cessation
- 1976-07-20 FI FI762086A patent/FI62667C/en not_active IP Right Cessation
- 1976-07-20 SE SE7608265A patent/SE426490B/en not_active IP Right Cessation
- 1976-07-20 DK DK327576A patent/DK154950C/en not_active IP Right Cessation
- 1976-07-20 PT PT65387A patent/PT65387B/en unknown
- 1976-07-20 NL NLAANVRAGE7608023,A patent/NL187442C/en not_active IP Right Cessation
- 1976-07-20 IE IE1602/76A patent/IE43496B1/en not_active IP Right Cessation
- 1976-07-20 BG BG7633791A patent/BG26526A3/xx unknown
- 1976-07-21 YU YU1794/76A patent/YU39969B/en unknown
- 1976-07-21 DE DE19762632870 patent/DE2632870A1/en active Granted
-
1977
- 1977-08-16 ES ES461630A patent/ES461630A1/en not_active Expired
- 1977-08-16 ES ES461631A patent/ES461631A1/en not_active Expired
-
1980
- 1980-03-20 HK HK141/80A patent/HK14180A/en unknown
- 1980-12-11 SE SE8008713A patent/SE435621B/en not_active IP Right Cessation
-
1981
- 1981-12-30 MY MY17/81A patent/MY8100017A/en unknown
-
1982
- 1982-05-21 KE KE3215A patent/KE3215A/en unknown
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4501749A (en) * | 1983-10-31 | 1985-02-26 | Merck & Co., Inc. | Peripherally selective dopamine antagonists in the treatment of ocular hypertension |
EP0140789A2 (en) * | 1983-10-31 | 1985-05-08 | Merck & Co. Inc. | Use of peripherally selective dopamine antagonists for the preparation of a medicament for the topical treatment of ocular hypertension |
EP0140789A3 (en) * | 1983-10-31 | 1987-12-02 | Merck & Co. Inc. | Ophthalmic composition containing a peripherally selective dopamine antagonist, for the treatment of ocular hypertension |
US8394786B2 (en) | 2003-05-27 | 2013-03-12 | Janssen Pharmaceutica N.V. | Quinazoline derivatives |
EA009064B1 (en) * | 2003-05-27 | 2007-10-26 | Янссен Фармацевтика Н. В. | Macrocyclic quinazoline derivatives as antiproliferative agents |
AU2004243487B2 (en) * | 2003-05-27 | 2009-12-03 | Janssen Pharmaceutica N.V. | Macrocyclic quinazoline derivatives as antiproliferative agents |
US7648975B2 (en) | 2003-05-27 | 2010-01-19 | Janssen Pharmaceutica N.V. | Macrocyclic quinazoline derivatives as antiproliferative agents |
EP2305687A1 (en) * | 2003-05-27 | 2011-04-06 | Janssen Pharmaceutica NV | Quinazoline derivatives |
KR101143878B1 (en) * | 2003-05-27 | 2012-05-24 | 얀센 파마슈티카 엔.브이. | Macrocyclic quinazoline derivatives as antiproliferative agents |
US9273013B2 (en) | 2003-05-27 | 2016-03-01 | Janssen Pharmaceutica Nv | Quinazoline derivatives |
WO2004105765A1 (en) * | 2003-05-27 | 2004-12-09 | Janssen Pharmaceutica N.V. | Macrocyclic quinazoline derivatives as antiproliferative agents |
US8772272B2 (en) | 2003-12-18 | 2014-07-08 | Janssen Pharmaceutica Nv | Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents |
US8933067B2 (en) | 2003-12-18 | 2015-01-13 | Janssen Pharmaceutica Nv | Pyrido and pyrimidopyrimidine derivatives as anti-profilerative agents |
US9688691B2 (en) | 2004-12-08 | 2017-06-27 | Janssen Pharmaceutica Nv | Macrocyclic quinazole derivatives and their use as MTKI |
US10208062B2 (en) | 2004-12-08 | 2019-02-19 | Janssen Pharmaceutica Nv | Macrocyclic quinazole derivatives and their use as MTKI |
US8492377B2 (en) | 2006-07-13 | 2013-07-23 | Janssen Pharmaceutica Nv | MTKI quinazoline derivatives |
US8318731B2 (en) | 2007-07-27 | 2012-11-27 | Janssen Pharmaceutica Nv | Pyrrolopyrimidines |
US8846929B2 (en) | 2007-08-31 | 2014-09-30 | Purdue Pharma L.P. | Substituted-quinoxaline-type piperidine compounds and the uses thereof |
US9278967B2 (en) | 2007-08-31 | 2016-03-08 | Purdue Pharma L.P. | Substituted-quinoxaline-type piperidine compounds and the uses thereof |
US9527840B2 (en) | 2007-08-31 | 2016-12-27 | Purdue Pharma L.P. | Substituted-quinoxaline-type piperidine compounds and the uses thereof |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1542514A (en) | 1-(benzazolylalkyl)piperidine derivatives | |
DE3363545D1 (en) | Substituted 1,4-dihydropyridines, method for their preparation and their use as pharmaceuticals | |
DK153545C (en) | ANALOGY PROCEDURE FOR PREPARING N-SUBSTITUTED DERIVATIVES OF 3,4,5-TRIHYDROXY-2-HYDROXYMETHYL-PIPERIDINE | |
SE7604476L (en) | PROCEDURE FOR PREPARING 1- (3,3,3-TRIARYLPROPYL) -4-PHENYL-4-PIPERIDINEMETHANOL COMPOUNDS | |
ES452200A1 (en) | 1-Benzazolylalkyl-4-substituted-piperidines | |
SE7612964L (en) | TIENAMYCIN DERIVATIVES | |
ES451768A1 (en) | N-aryl-n-(1-l-4-piperidinyl)-arylacetamides | |
ES482138A1 (en) | Phenylpiperidine derivatives, processes for their preparation and pharmaceutical compositions containing them. | |
GB1503280A (en) | Aminoalkanesulphonic acid derivative | |
ES8308881A1 (en) | Diaryl-imidazole compounds, methods for their preparation, pharmaceutical drugs containing them and their use. | |
GB2104515B (en) | Sulphimines | |
SE7706693L (en) | METHODS OF PRODUCING HYDRAZINOPYRIDAZINE DERIVATIVES | |
ES439180A1 (en) | Substituted hydroxyphenyl-piperidones | |
ES327879A1 (en) | A procedure for the obtaining of new i-cicloalcohiledenetil-4-fenil-piperidinas. (Machine-translation by Google Translate, not legally binding) | |
JPS52153963A (en) | Novel 3-substituted pyrrolidine derivatives and method of preparing same | |
GR34663B (en) | METHOD FOR THE PREPARATION OF PHENYLAMINETHANOL PRODUCERS. | |
GB1530807A (en) | 1,1-diphenyl-4-(substituted-amino)butanes | |
ES383789A1 (en) | Procedure for the obtaining of derivatives of 2H-indeno (1,2-c) pyridine. (Machine-translation by Google Translate, not legally binding) | |
ES444064A1 (en) | 1-(2'-aroyl ethyl)2-(4"-carbamoyl-methyl-piperazin-1"-yl methyl)benzimidazoles their therapeutical applications and method for their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
704A | Declaration that licence is not available as of right for an excepted use (par. 4a/1977) | ||
PE20 | Patent expired after termination of 20 years |
Effective date: 19960629 |